VistaGen Therapeutics Inc (VTGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $8.01M
Last updated: Nov 17, 2026 at 11:04 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 16.9% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 45.5, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about VTGN
News
VTGN Valuation
VTGN Profitability: Margins, ROIC and FCF
VistaGen Therapeutics (VTGN) has a gross margin of 100.0%, an operating margin of -2543.0% and a net margin of 0.0%. It posts a -2555.7% FCF margin.
- Gross margin
- 100.0%
- Operating margin
- -2543.0%
- Net margin
- 0.0%
- ROE
- -145.0%
- FCF margin
- -2555.7%
VistaGen Therapeutics Competitors
The companies most similar to VistaGen Therapeutics (VTGN) include Biovie, Tempest Therapeutics and Theriva Biologics.
Sector: Healthcare
Companies most similar to VistaGen TherapeuticsVTGN Analyst Ratings
VistaGen Therapeutics (VTGN) has a Hold consensus from 4 analysts: 0 Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell.
- Consensus
- Hold
- Analysts
- 4
- Strong Buy
- 0
- Buy
- 0
- Hold
- 4
- Sell
- 0
- Strong Sell
- 0
VTGN Bull Case vs Bear Case
Bear case
- VTGN's quarterly revenue changed -46.5% year over year.
VTGN Earnings: Beat Rate and Next Report
VistaGen Therapeutics (VTGN) beat the EPS estimate in 5 of the last 8 quarters (62.5%). Its next report is expected on Feb 10, 2027.
- Beat rate
- 5 of 8 quarters (62.5%)
- Average surprise
- 10.9%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.37
- Estimate revisions (30 days, fiscal period ending Dec 31, 2026)
- 0 up, 2 down
VTGN Earnings Date
VTGN reports Feb 10, 2027. The date is estimated.
VTGN Earnings Call
The latest VTGN earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptVTGN ETF Holders
GNG tracks 3 ETFs that hold VTGN. The largest weights:
- Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 13, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About VTGN
When does VTGN report earnings?
VistaGen Therapeutics Inc (VTGN) is expected to report earnings on Feb 10, 2027.
Does VTGN pay dividends?
VistaGen Therapeutics Inc (VTGN) does not currently pay a regular dividend.
What is VTGN's market cap?
VistaGen Therapeutics Inc (VTGN) has a market capitalization of $8.01M with a current stock price of $0.18.
VTGN pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.